Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Endocrinol Metab Clin North Am ; 45(4): 845-874, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27823608

RESUMO

Newer insulin products have advanced the evolution of insulin replacement options to more accurately mimic natural insulin action. There are new, modified, and concentrated insulins; administration devices calibrated for both increased concentrations and administration accuracy to improve adherence and safety; and inhaled insulin. There are new combinations of longer-acting basal insulin and rapid-acting insulin or glucagon like protein-1 receptor agonists. Existing insulin replacement designs and methods can be updated using these tools to improve efficacy and safety. Individualized decisions to use them should be based on patient physiologic needs, self-care ability, comorbidities, and cost considerations.


Assuntos
Hipoglicemiantes/administração & dosagem , Hipoglicemiantes/farmacologia , Insulinas/administração & dosagem , Insulinas/farmacologia , Receptores de Peptídeos Semelhantes ao Glucagon/agonistas , Humanos , Insulina Glargina/farmacologia , Insulina de Ação Prolongada/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA